GFAP and Parkinson disease: In addition to the increase in GFAP expression, it has been shown that S100b levels increase during reactive astrogliosis in SNpc and striatum of PD patients, suggesting that this protein could play an important role in disease progression (Jackson-Lewis and Przedborski, 2007).